| Stage | TAYD | % of rev | ULBI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7M | 100.00% | $48M | 100.00% | ULBI ×6.57 |
| Gross profit | $2M | 29.57% | $14M | 28.92% | TAYD +0.7pp |
| Operating income | $38,454 | 0.53% | $3M | 7.17% | ULBI +6.6pp |
| Pre-tax income | $456,933 | 6.26% | $3M | 6.23% | 0.0pp |
| Net income | $456,933 | 6.26% | $3M | 5.25% | TAYD +1.0pp |
| Stage | TAYD | ULBI | Gap · A − B |
|---|---|---|---|
| Revenue | $7M100.00% | $48M100.00% | ULBI ×6.57 |
| Gross profit | 29.57%$2M | 28.92%$14M | TAYD +0.7pp |
| Operating income | 0.53%$38,454 | 7.17%$3M | ULBI +6.6pp |
| Pre-tax income | 6.26%$456,933 | 6.23%$3M | 0.0pp |
| Net income |
| 6.26%$456,933 |
| 5.25%$3M |
| TAYD +1.0pp |
None
No disclosed counterparties: TAYD.